AFP and liver cancer: No significant differences in Barcelona Clinic Liver Cancer (BCLC) stage, mean alpha-fetoprotein (AFP) level, vascular invasion, or distant metastasis were detected between the low- and high-expression groups, suggesting that CX3CL1 expression is not associated with these clinicopathological features.